MedPath

Preoperative steroid before operation for giant incisional hernia

Phase 1
Conditions
Patients who undergo abdominal wall reconstruction for repair of a giant ventral hernia
MedDRA version: 19.0Level: HLTClassification code 10021620Term: Incisional herniasSystem Organ Class: 100000004856
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2015-004916-39-DK
Lead Sponsor
Digestive Disease Center, Bispebjerg Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Ventral incisional hernia with horizontal fascial defect > 10 cm described at either computed tomography scan or clinical assessment
Planned elective open hernia repair
Ability to speak and understand Danish
Ability to give written and oral informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 15
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 25

Exclusion Criteria

Daily use of systemic glucocorticoid
New York Heart Association class 3-4 heart disease
Chronic renal failure (eGFR < 60 ml/min per 1.73 m2)
Insulin-dependent diabetes
Excessive abuse of alcohol
Known allergy to methylprednisolone or any substance in study medicine
Planned pregnancy within three months postoperatively
Pregnancy, evaluated by pregnancy test preoperatively
Breastfeeding
Actively treated ulcer disease up to one month preoperatively

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To examine the effects of methylprednisolone on postoperative pain after giant ventral hernia repair.;Secondary Objective: To examine the effects of methylprednisolone on postoperative nausea and recovery after giant ventral hernia repair.;Primary end point(s): Self-reported pain at rest on af numerical rating scale (0-10);Timepoint(s) of evaluation of this end point: First postoperative day at 8 am<br>
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): Pain at rest<br>Fatigue<br>Nausea<br>Vomiting<br>Rescue analgesia intake<br>Time to discharge<br>30-day complications<br>;Timepoint(s) of evaluation of this end point: The first five postoperative days at 8 am and 8 pm.<br>Complications occuring within first 30 days postoperatively
© Copyright 2025. All Rights Reserved by MedPath